Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Head & Neck|December 22, 2022
Ninety-day mortality following transoral robotic surgery or radiation at Commission on Cancer-accredited facilitiesJames R Janopaul-Naylor, Manali Rupji, Rachel A Tobillo, et al.
Cancer Discovery|September 22, 2021
Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR-Mutated Non-Small Cell Lung CancerPasi A Jänne, Christina Baik, Wu-Chou Su, et al.
BMC Cancer|August 30, 2019
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapyMehmet Asim Bilen, Julie M Shabto, Dylan J Martini, et al.
CA: a Cancer Journal for Clinicians|May 29, 2025
Reirradiation: Standards, challenges, and patient-focused strategies across tumor typesArnaud Beddok, Jonas Willmann, Anna Embring, et al.
British Journal of Cancer|July 25, 2020
Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinomaR Donald Harvey, Bradley C Carthon, Colleen Lewis, et al.
Cancers|December 17, 2024
Characterization of Somatostatin Receptor 2 Gene Expression and Immune Landscape in Sinonasal MalignanciesElisabetta Xue, Dara Bracken-Clarke, Harris Krause, et al.
Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Impact of MET inhibitors on survival among patients with non-small cell lung cancer harboring MET exon 14 mutations: a retrospective analysisMark M Awad, Giulia C Leonardi, Sasha Kravets, et al.
Cancers|April 3, 2021
Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II StudyChristine H Chung, Marcelo Bonomi, Conor E Steuer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2022
Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell CarcinomaChristine H Chung, Jiannong Li, Conor E Steuer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2024
Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker AnalysisNabil F Saba, Ritu Chaudhary, Kedar Kirtane, et al.
Pageof 8